Deal title Principal company/nonprofit Partner company/nonprofit Value (US$M) Start date
Biofabri and IAVI to develop Mtbvac for tuberculosis Biofabri SL International AIDS Vaccine Initiative Payment unspecified 11/19/19
Novo and Broad Institute of MIT launched the Novo Broad Greenhouse to discover new therapies Broad Institute Inc. Novo Holdings A/S Payment unspecified 11/19/19
Pideka and CIB to develop cannabis-based products for human diseases, including colon cancer Corporation for Biological Research Pideka SAS Payment unspecified 11/8/19
Amgen and DCRI to conduct Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 inhibitors (cvMOBIUS) study for PCSK9 inhibitors against atherosclerotic cardiovascular disease Duke Clinical Research Institute Amgen Inc. Payment unspecified 11/15/19
Gwo Xi Stem Cell and Vinmec Research to develop GXIPC-1 for diabetes Gwo Xi Stem Cell Applied Technology Co Ltd Vinmec Research Institute of Stem Cell and Gene Technology Payment unspecified 11/5/19
LSU Health to grant worldwide rights of TV-1001SR along with intellectual property relating to sustained release of sodium nitrite to Janone Louisiana State University Medical Center Foundation Janone Inc. $6.75 11/1/19
Iota and Massachusetts General Hospital to develop Phoenix drug screening platform for glioblastoma Massachusetts General Hospital Iota Pharmaceuticals Ltd. Payment unspecified 11/20/19
Takeda to develop and commercialize MD Anderson’s cord blood-derived chimeric antigen receptor-directed natural killer cell therapies for B cell malignancies and other cancers MD Anderson Cancer Center Takeda Pharmaceutical Co. Ltd. Payment unspecified 11/5/19
Memorial Sloan Kettering Cancer Center and Enterome to evaluate gut microbiome-derived antigens for development as cancer immunotherapies Memorial Sloan-Kettering Cancer Center Enterome SA Payment unspecified 11/7/19
Mount Sinai to conduct phase II study for Brainstorm's Nurown in participants with progressive multiple sclerosis Mount Sinai Medical Center Brainstorm Cell Therapeutics Inc. Payment unspecified 11/25/19
Temprian Therapeutics to acquire intellectual property rights related to heat shock protein, HSP70i from Northwestern University to develop TT-01 against vitiligo Northwestern University Temprian Therapeutics Inc. Payment unspecified 11/20/19
NINDS to award contract to Psychogenics for preclinical screening platform for pain Psychogenics Inc. National Institute of Neurological Disorders and Stroke $49.90 11/6/19
Universitat de Barcelona to advance the efficiency of Boehringer Ingelheim's nintedanib against lung cancer Universitat de Barcelona Boehringer Ingelheim International GmbH Payment unspecified 11/19/19
Qiagen to license University of Bonn's epigenomic immune checkpoint gene methylation test University of Bonn Qiagen NV Payment unspecified 11/5/19
Avita and University of Colorado School of Medicine to develop spray-on treatment of genetically modified cells for epidermolysis bullosa University of Colorado School of Medicine Avita Medical Payment unspecified 11/24/19
Teva and Weizmann Institute to identify antibodies for cancer Weizmann Institute of Science Teva Pharmaceutical Industries Ltd. Payment unspecified 11/25/19

No Comments